MACDONALD LAURA ANN 4
4 · COGNEX CORP · Filed Feb 13, 2026
Research Summary
AI-generated summary of this filing
Cognex (CGNX) VP Laura MacDonald Exercises Options, Sells Shares
What Happened
Laura Ann MacDonald, Vice President and PAO of Cognex Corp (CGNX), exercised stock options and sold a total of 14,881 shares on Feb 12, 2026. She exercised 12,500 options at $38.39 each (cash paid $479,875) and sold 12,500 of those shares at $57.27 ($715,884). She also sold an additional 2,381 shares at $56.56 ($134,669). Total proceeds from the sales were about $850,553. The transactions include option exercises (acquisitions) and open-market sales; the sales appear to have been executed under a pre-established Rule 10b5-1 trading plan.
Key Details
- Transaction date: 2026-02-12. Prices and amounts:
- Exercised 12,500 options at $38.39 each — cost $479,875 (reported as acquisition).
- Sold 12,500 shares at $57.27 — proceeds $715,884.
- Sold 2,381 shares at $56.56 — proceeds $134,669.
- Total proceeds from reported sales: ~$850,553.
- Shares owned after the transactions: Not specified in the filing provided.
- Footnotes: Sales and option exercises were made pursuant to a Rule 10b5-1 trading plan (F1, F2). A footnote (F3) indicates some reported shares are held by the reporting person’s child and the reporting person disclaims beneficial ownership except for any pecuniary interest.
- Filing timeliness: No late filing was indicated in the information provided.
Context
Because MacDonald both exercised options and sold shares the same day, the activity resembles a partial cashless exercise (exercise followed by sale). The presence of a Rule 10b5-1 plan typically means the trades were pre-arranged under an automatic schedule, which is common for insiders and reduces the likelihood that these sales were opportunistic market-timing. As always, sales by executives can be routine (tax or diversification) and do not by themselves indicate a change in company outlook.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-02-12$56.56/sh−2,381$134,669→ 2,212 total - Exercise/Conversion
Common Stock
[F2]2026-02-12$38.39/sh+12,500$479,875→ 14,712 total - Sale
Common Stock
[F2]2026-02-12$57.27/sh−12,500$715,884→ 2,212 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F2]2026-02-12−12,500→ 0 totalExercise: $38.39From: 2018-02-21Exp: 2027-02-21→ Common Stock (12,500 underlying)
- 20(indirect: By Children)
Common Stock
[F3] - 33,168
Non-Qualified Stock Option (right to buy)
Exercise: $33.04From: 2026-02-18Exp: 2035-02-18→ Common Stock (33,168 underlying) - 37,698
Non-Qualified Stock Option (right to buy)
Exercise: $39.44From: 2025-02-20Exp: 2034-02-20→ Common Stock (37,698 underlying) - 30,492
Non-Qualified Stock Option (right to buy)
Exercise: $47.21From: 2024-02-21Exp: 2033-02-21→ Common Stock (30,492 underlying) - 10,000
Non-Qualified Stock Option (right to buy)
Exercise: $48.28From: 2022-05-01Exp: 2029-05-01→ Common Stock (10,000 underlying) - 42,500
Non-Qualified Stock Option (right to buy)
Exercise: $50.94From: 2021-02-18Exp: 2030-02-18→ Common Stock (42,500 underlying) - 30,000
Non-Qualified Stock Option (right to buy)
Exercise: $51.49From: 2020-02-19Exp: 2029-02-19→ Common Stock (30,000 underlying) - 15,000
Non-Qualified Stock Option (right to buy)
Exercise: $56.44From: 2019-02-20Exp: 2028-02-20→ Common Stock (15,000 underlying) - 23,891
Non-Qualified Stock Option (right to buy)
Exercise: $64.43From: 2023-02-22Exp: 2032-02-22→ Common Stock (23,891 underlying) - 13,946
Non-Qualified Stock Option (right to buy)
Exercise: $90.50From: 2022-02-16Exp: 2031-02-16→ Common Stock (13,946 underlying) - 2,754
Restricted Stock Unit
Exercise: $0.00From: 2024-02-21Exp: 2026-02-21→ Common Stock (2,754 underlying) - 5,071
Restricted Stock Unit
Exercise: $0.00From: 2025-02-20Exp: 2027-02-20→ Common Stock (5,071 underlying) - 982
Restricted Stock Unit
Exercise: $0.00From: 2025-03-15Exp: 2027-03-15→ Common Stock (982 underlying) - 12,107
Restricted Stock Unit
Exercise: $0.00From: 2026-02-18Exp: 2028-02-18→ Common Stock (12,107 underlying)
Footnotes (3)
- [F1]These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F3]Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.